StonvexLoading…
StonvexStonvexStonvexCore line items from LYB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $30.15B | $33.39B | $33.34B | $50.45B |
Operating Income | $-420.00M | $1.92B | $2.73B | $5.10B |
Net Income | $-738.00M | $1.37B | $2.12B | $3.89B |
EPS (Diluted) | $-2.34 | $4.15 | $6.46 | $11.81 |
Total Assets | $34.00B | $35.75B | $37.00B | $36.37B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $3.44B | $3.38B | $3.39B | $2.15B |
Free Cash Flow OCF − CapEx | $384.00M | $1.98B | $3.41B | $4.23B |
Shares Outstanding | 322.08M | 323.89M | 324.48M | 325.72M |